advanced cancer

American Society of Clinical Oncology; Clinical Cancer Advances 2018: ASCO's Annual Report on Progress Against Cancer
January 30, 2018
Greg Guthrie, ASCO staff

CAR T-Cell Immunotherapy: The 2018 Advance of the Year

English
gregguthrie

The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 5, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: Advances in Immunotherapy for Multiple Myeloma and Mesothelioma, and Targeted Therapies for Non-Small Cell Lung Cancer and HER2-Positive Breast Cancer

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 3, 2017
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing

English
gregguthrie

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.

Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 2, 2017
Monika Sharda, ASCO staff

ASCO Annual Meeting 2017: Improving Survivorship Care

English
Monika.Sharda

Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Here are some of today’s key research highlights, with a focus on enhancing survivors’ health.

Read More >>
July 19, 2016

TAPUR: Looking for Answers in Targeted Therapy

English

The Targeted Agent and Profiling Utilization Registry (TAPUR) study is ASCO’s first clinical trial. In this podcast, ASCO Chief Medical Officer Dr. Richard Schilsky discusses TAPUR and why it is important to patients and the medical community.

Read More >>
2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
June 3, 2016
Greg Guthrie, ASCO staff

ASCO Annual Meeting: Existing Treatments Used in New Ways

English
gregguthrie

Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. In today’s studies, researchers reveal how they look for new ways to use existing treatments in order to improve cancer care.

Read More >>

Pages

Subscribe to RSS - advanced cancer